✦ LIBER ✦

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

✍ Scribed by J. Barker; M. Hoffmann; G. Wozel; J.-P. Ortonne; H. Zheng; H. van Hoogstraten; K. Reich

Book ID: 108672003
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 346 KB
Volume: 165
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2011.10615.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once weekly administration of etanercept

Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension

✍ P.C.M. Van De Kerkhof; S. Segaert; M. Lahfa; T.A. Luger; Z. Karolyi; A. Kaszuba; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

Impact of adalimumab treatment on health

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views